Hospital Universitario de Valme -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study

    BMC Cancer, Vol. 22, Núm. 1